Quick Answer
Minerva Neurosciences, Inc. reported Operating Income Loss of -$15.10 million for the year ending 2025.
- Minerva Neurosciences, Inc. showed an increase of +30.9% in Operating Income Loss from 2024 to 2025.
- This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: -$2.04 million | Q1 2014: -$2.62 million | Q2 2014: -$17.65 million | Q3 2014: -$27.15 million | Q4 2014: -$7.45 million | Q1 2015: -$5.88 million | Q2 2015: -$6.33 million | Q3 2015: -$5.71 million | Q4 2015: -$8.19 million | Q1 2016: -$7.76 million | Q2 2016: -$4.97 million | Q3 2016: -$8.23 million | Q4 2016: -$9.24 million | Q1 2017: -$10.49 million | Q2 2017: -$9.75 million | Q3 2017: -$11.41 million | Q4 2017: -$9.53 million | Q1 2018: -$12.74 million | Q2 2018: -$12.94 million | Q3 2018: -$12.42 million | Q4 2018: -$13.63 million | Q1 2019: -$16.31 million | Q2 2019: -$12.90 million | Q3 2019: -$14.28 million | Q4 2019: -$32.37 million | Q1 2020: -$12.27 million | Q2 2020: $29.51 million | Q3 2020: -$8.09 million | Q4 2020: -$7.30 million | Q1 2021: -$7.51 million | Q2 2021: -$8.96 million | Q3 2021: -$7.52 million | Q1 2022: -$7.99 million | Q2 2022: -$6.97 million | Q3 2022: -$5.21 million | Q1 2023: -$5.35 million | Q2 2023: -$4.52 million | Q3 2023: -$6.08 million | Q1 2024: -$6.68 million | Q2 2024: -$6.28 million | Q3 2024: -$4.37 million | Q1 2025: -$3.90 million | Q2 2025: -$3.37 million | Q3 2025: -$2.84 million.
- Over the full 13 years of available data (2013 to 2025), Minerva Neurosciences, Inc.'s Operating Income Loss has declined by 375.7%.
- Historical annual values: Fiscal year 2025: -$15.10 million | Fiscal year 2024: -$21.85 million | Fiscal year 2023: -$23.12 million | Fiscal year 2022: -$25.23 million | Fiscal year 2021: -$45.37 million | Fiscal year 2020: $1.85 million | Fiscal year 2019: -$75.87 million | Fiscal year 2018: -$51.73 million | Fiscal year 2017: -$41.17 million | Fiscal year 2016: -$30.19 million | Fiscal year 2015: -$26.11 million | Fiscal year 2014: -$54.87 million | Fiscal year 2013: -$3.17 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: